Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Diabetes Metab Res Rev. 2016 Sep;32(6):572-80. doi: 10.1002/dmrr.2770. Epub 2016 Jan 26.
In this study, we evaluate the association between triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio and total cholesterol (TC) to HDL (TC/HDL) ratio and the risks of type 2 diabetes (T2D) in an Iranian high-risk population.
We analysed 7-year follow-up data (n = 1771) in non-diabetic first-degree relatives of consecutive patients with T2D 30-70 years old. The primary outcome was the diagnosis of T2D based on repeated oral glucose tolerance tests. We used Cox proportional hazard models to estimate hazard ratio for incident T2D across tertiles of TG/HDL and TC/HDL ratios and plotted a receiver operating characteristic (ROC) curve to assess discrimination.
The highest tertile of TG/HDL and TC/HDL ratios compared with the lowest tertile was not associated with T2D in age- and gender-adjusted models (HR 0.99, 95% CI: 0.88, 1.11 for TG/HDL ratio and 1.10, 95% CI: 0.97, 1.23 for TC/HDL ratio). Further adjustment for waist circumference or body mass index, fasting plasma glucose, and low-density lipoprotein cholesterol did not appreciably alter the hazard ratio compared with the age- and gender-adjusted model. The area under the ROC curve for TG/HDL ratio was 57.7% (95% CI: 54.0, 61.5) and for TC/HDL ratio was 55.1% (95% CI: 51.2, 59.0).
TG/HDL and TC/HDL ratios were not robust predictors of T2D in high-risk individuals in Iran. Copyright © 2015 John Wiley & Sons, Ltd.
本研究旨在评估伊朗高危人群的甘油三酯与高密度脂蛋白胆固醇(TG/HDL)比值和总胆固醇与高密度脂蛋白胆固醇(TC/HDL)比值与 2 型糖尿病(T2D)风险之间的关联。
我们对年龄在 30-70 岁、无糖尿病的 T2D 连续患者一级亲属的 7 年随访数据(n=1771)进行了分析。主要结局为基于重复口服葡萄糖耐量试验的 T2D 诊断。我们使用 Cox 比例风险模型来估计 TG/HDL 和 TC/HDL 比值三分位的 T2D 发生率的风险比,并绘制了受试者工作特征(ROC)曲线来评估判别能力。
在年龄和性别调整模型中,与最低三分位相比,TG/HDL 和 TC/HDL 比值的最高三分位与 T2D 无关(TG/HDL 比值的 HR 为 0.99,95%CI:0.88,1.11;TC/HDL 比值的 HR 为 1.10,95%CI:0.97,1.23)。进一步调整腰围或体重指数、空腹血糖和低密度脂蛋白胆固醇后,与年龄和性别调整模型相比,风险比没有明显改变。TG/HDL 比值的 ROC 曲线下面积为 57.7%(95%CI:54.0,61.5),TC/HDL 比值的 ROC 曲线下面积为 55.1%(95%CI:51.2,59.0)。
在伊朗高危个体中,TG/HDL 和 TC/HDL 比值并不是 T2D 的可靠预测指标。版权所有 © 2015 约翰威立父子公司。